coronaviru
diseas
caus
emerg
pose
seriou
threat
global
public
health
econom
social
stabil
call
prompt
develop
therapeut
prophylact
studi
firstli
verifi
use
human
cell
receptor
spike
protein
mediat
high
membran
fusion
activ
compar
sarscov
heptad
repeat
sequenc
fusion
protein
possess
markedli
increas
thermost
well
higher
bind
affin
correspond
heptad
repeat
site
design
sequencebas
lipopeptid
fusion
inhibitor
term
show
highli
poent
activ
inibibit
proteinmedi
cellcel
fusion
pseudoviru
infect
also
inhibit
sarscov
pseudoviru
effici
moreov
strcutur
activ
relationship
sar
characterz
panel
truncat
lipopeptid
reveal
amino
acid
motif
critic
bind
antivir
capac
therefor
present
result
provid
import
inform
understand
entri
pathway
design
antivir
target
membran
fusion
step
late
decemb
new
infecti
respiratori
diseas
emerg
wuhan
china
pathogen
soon
identifi
novel
coronaviru
cov
initi
term
compris
subunit
exist
metast
prefus
conform
subunit
contain
receptorbind
domain
rbd
capabl
function
fold
independ
respons
viru
bind
cell
surfac
receptor
recent
studi
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
suggest
affin
rbd
higher
sarscov
may
contribut
significantli
increas
infect
transmiss
receptorbind
deem
trigger
larg
conform
chang
complex
destabil
prefus
trimer
result
shed
subunit
activ
fusogen
activ
subunit
illustr
fig
sequenc
structur
contain
ntermin
fusion
peptid
fp
heptad
repeat
heptad
repeat
transmembran
region
tm
cytoplasm
tail
ct
fusion
process
fp
expos
insert
target
cell
membran
lead
prehairpin
intermedi
bridg
viral
cell
membran
three
segment
selfassembl
trimer
coiledcoil
three
segment
fold
groov
surfac
inner
core
therebi
result
sixhel
bundl
structur
drive
two
membran
close
apposit
fusion
infect
found
differ
sarscov
protein
high
cell
fusion
activ
design
character
sever
earlier
time
point
would
like
experiment
verifi
whether
use
human
receptor
cell
entri
thu
gener
protein
pseudotyp
lentivir
particl
sarscov
vesicular
stomat
viru
vsvg
pseudovirus
also
prepar
comparison
shown
fig
three
pseudovirus
effici
infect
cell
stabli
overexpress
howev
infect
sarscov
dramat
decreas
cell
express
low
level
endogen
viru
control
vsvg
pesudoviru
enter
cell
even
effici
rel
infect
cell
compar
fusion
activ
viral
protein
cell
appli
dspbase
cellcel
fusion
assay
shown
fig
protein
sarscov
display
weak
fusion
activ
cell
show
significantli
increas
capac
mediat
cell
fusion
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
result
demonstr
overexpress
promot
cell
entri
sarscov
pseudovirus
well
proteinmedi
cellcel
fusion
activ
verifi
function
target
cell
observ
protein
significantli
increas
fusion
activ
protein
sarscov
therefor
compar
fusion
activ
viral
protein
differ
time
point
shown
fig
sarscov
protein
exhibit
appreci
fusion
activ
effector
cell
target
cell
cocultur
five
six
hour
sharp
contrast
protein
mediat
rapid
robust
cell
fusion
reaction
indic
fusion
kinet
curv
especi
cell
sarscov
sequenc
nine
amino
acid
substitut
eight
locat
within
core
site
wherea
two
virus
share
fulli
ident
sequenc
fig
order
explor
mechan
underli
highli
activ
fusion
activ
protein
synthes
two
peptid
correspond
sequenc
secondari
structur
determin
circular
dichroism
cd
spectroscopi
shown
fig
peptid
deriv
design
show
typic
conform
helix
content
wherea
peptid
sarscov
design
content
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
thermal
stabil
two
peptid
measur
shown
fig
exhibit
melt
temperatur
valu
c
respect
furthermor
synthes
peptid
contain
sequenc
term
interact
two
peptid
analyz
cd
spectroscopi
shown
fig
e
interact
form
complex
typic
structur
valu
c
respect
comparison
complex
form
much
stabl
complex
peptid
taken
togeth
result
suggest
might
evolv
increas
interact
domain
fusion
protein
thu
critic
determin
high
fusogen
activ
properti
inhibitor
absenc
presenc
target
mimic
peptid
shown
fig
unconjug
alon
larg
random
structur
valu
could
defin
contrast
lipopeptid
display
markedli
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
increas
helix
content
c
next
assess
helic
bind
stabil
inhibitor
two
target
mimic
peptid
shown
fig
next
sought
determin
antivir
function
peptid
firstli
inhibitori
activ
proteinmedi
cellcel
fusion
examin
dspbase
cell
fusion
assay
describ
shown
fig
tabl
tabl
expect
inhibitori
activ
control
viru
vsvg
indic
antivir
specif
therefor
conclud
highli
potent
fusion
inhibitor
sarscov
differ
ctermin
truncat
inhibitor
templat
antivir
function
markedli
impair
underscor
role
ctermin
residu
basi
result
expect
two
termin
truncat
antivir
inact
inde
cd
data
suggest
nand
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ctermin
sequenc
contribut
critic
bind
inhibitor
tabl
analyz
secondari
structur
thermost
cd
spectroscopi
found
peptid
deriv
fusion
protein
display
much
higher
thermost
peptid
fusion
protein
sarscov
consist
content
melt
temperatur
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
peptid
complex
peptid
higher
sarscov
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
suggest
mainli
util
plasma
membran
fusion
pathway
cell
entri
sequenc
analys
reveal
harbor
cleavag
site
protein
although
role
proteinmedi
membran
fusion
viral
lifecycl
need
character
one
specul
furinmedi
precleavag
site
infect
cell
might
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
infect
assay
describ
previous
produc
pseudovirus
cell
cotransfect
backbon
plasmid
encod
envdefect
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
